Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Industry Summary Page

Industry: pharmaceuticals
Penalty Total since 2000: $116,245,163,450
Number of Records: 1,270
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. The totals are adjusted to account for the fact that each parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.
Top 10 Current Parent CompaniesTotal Penalty $Number of Records
Johnson & Johnson$24,497,162,77088
Pfizer$10,948,368,52398
Merck$10,710,400,03189
Teva Pharmaceutical Industries$10,242,576,79696
GlaxoSmithKline$9,572,803,40650
Purdue Pharma$9,278,372,78711
AbbVie$7,560,456,40484
Takeda Pharmaceutical$3,987,516,44732
Endo International$3,311,990,66730
Eli Lilly$2,831,299,67626

Individual Penalty Records:

Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.

Download results as CSV or XML or Save your search (Click here for information on download subscriptions)
CompanyCurrent Parent sort iconPrimary Offense TypeYearAgencyPenalty Amount
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009FDA$1,415,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2005FDA$36,000,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010AR-AG$18,500,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010MS-AG$18,500,000
Eli LillyEli Lillyoff-label or unapproved promotion of medical products2010LA-AG$20,000,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009CT-AG$25,100,000
Eli Lilly and Co.Eli Lillyoff-label or unapproved promotion of medical products2009ID-AG$13,000,000
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2009MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $361,828,456
Eli Lilly and CompanyEli Lillyoff-label or unapproved promotion of medical products2008MULTI-AG$62,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010FDA$11,000,000
Eisai Inc.Eisaioff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,658,249
Cypress Pharmaceutical Inc.Currax Pharmaceuticalsoff-label or unapproved promotion of medical products2012FDA$2,800,000
Bristol-Myers Squibb CompanyBristol-Myers Squibboff-label or unapproved promotion of medical products2007DOJ_CIVIL$515,000,000
Bristol-Myers SquibbBristol-Myers Squibboff-label or unapproved promotion of medical products2016MULTI-AG$19,500,000
Celgene Corp.Bristol-Myers Squibboff-label or unapproved promotion of medical products2017MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $20,700,000
Boehringer Ingelheim Pharmaceuticals Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012FDA$95,000,000
Boehringer Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2017MULTI-AG$13,500,000
Boehringer-Ingelheim Pharmaceuticals, Inc.Boehringer Ingelheimoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $95,000,000
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007DOJ_CIVIL$9,800,000
ISTA Pharmaceuticals, Inc.Bausch Healthoff-label or unapproved promotion of medical products2013MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $390,253
Medicis Pharmaceutical CorporationBausch Healthoff-label or unapproved promotion of medical products2007MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $4,000,000
AstraZeneca LPAstraZenecaoff-label or unapproved promotion of medical products2010FDA$520,000,000
AstraZenecaAstraZenecaoff-label or unapproved promotion of medical products2013KY-AG$5,500,000
AstraZeneca PharmaceuticalsAstraZenecaoff-label or unapproved promotion of medical products2011MULTI-AG$68,500,000
AstraZeneca Pharmaceuticals LPAstraZenecaoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $218,092,993
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$5,909
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2015CMS$9,440
Amneal Pharmaceutical, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$10,788
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2016CMS$12,367
Amneal Pharmaceuticals, LLCAmneal PharmaceuticalsMedicare Coverage Gap Discount Program violation2019CMS$12,968
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012FDA$762,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $612,000,000
Amgen Inc.Amgenoff-label or unapproved promotion of medical products2015MULTI-AG$71,000,000
Alnylam Pharmaceuticals, Inc.Alnylam PharmaceuticalsMedicare Coverage Gap Discount Program violation2023CMS$31,959
Abbott Laboratories Inc.AbbVieoff-label or unapproved promotion of medical products2012FDA$1,500,000,000
Forest Pharmaceuticals Inc.AbbVieoff-label or unapproved promotion of medical products2011FDA$164,000,000
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010FDA$600,000,000
Warner Chilcott PLCAbbVieoff-label or unapproved promotion of medical products2015FDA$125,000,000
Actavis Kadian, LLCAbbVieMedicare Coverage Gap Discount Program violation2013CMS$116,703
Abbott LaboratoriesAbbVieoff-label or unapproved promotion of medical products2012MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $339,148,643
Allergan Inc.AbbVieoff-label or unapproved promotion of medical products2010MULTI-AG(*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $14,750,000
Allergan Finance LLCAbbVieoff-label or unapproved promotion of medical products2021NY-AG$200,000,000
Allergan Ltd. et al.AbbVieoff-label or unapproved promotion of medical products2022FL-AG$134,200,000
Allergan Ltd.AbbVieoff-label or unapproved promotion of medical products2022RI-AG$7,500,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022WV-AG$78,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022MULTI-AG$2,370,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022CA-SFCA$27,000,000
AllerganAbbVieoff-label or unapproved promotion of medical products2022MULTI-AG$4,800,000
Allergan PLCAbbVieoff-label or unapproved promotion of medical products2023KY-AG$48,666,145
AllerganAbbVieoff-label or unapproved promotion of medical products2024MD-AG$38,166,450
Advanced Neuromodulation Systems, Inc.Abbott LaboratoriesHHS civil monetary penalties2007HHSOIG$2,950,000
Abbott LaboratoriesAbbott Laboratoriesoff-label or unapproved promotion of medical products2018USAO$25,000,000
(*): Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting.